Health Protocol Catalog

Three clinical protocols demonstrating the M_bio → ω_kine paradigm: aberrant biological oscillators treated as destructive-interference tensor waves rather than static chemical locks. Each protocol targets a real disease at a level chemistry alone cannot reach.

Every claim on this page is warranted by a substrate row. Atom IDs are listed alongside each protocol; the same content renders into the chat narration via FranklinMeaningRenderer in the operator's locale, and is the body of the corresponding franklin_ontology_facts row that the chat oracle reads on demand.

---

The 3 protocols in plain terms

Tuberculosis — MmpL3 transporter targeting

Substrate atom: narration_health_tb_teaching · FOF-160

What it does: Targets the MmpL3 transporter on Mycobacterium tuberculosis at its resonant kinematic frequency. M_bio → ω_kine: the transcription factor's vibrational mode is the actual handle, not its chemical site.

CALORIE: First-line drugs (rifampicin, isoniazid) are losing to multi-drug-resistant TB. Frequency-targeted destructive interference reaches resistance mechanisms chemistry cannot.

CURE: TB kills ~1.3 million people per year. Multi-drug-resistant TB has 50% mortality even with treatment. Heals the antimicrobial-resistance deficit — frequency targeting cannot be bypassed by point mutations the way chemical binding can.

---

Acute Myeloid Leukemia — EVI1 / MECOM inv(3) chromatin loop disruption

Substrate atom: narration_health_aml_teaching · FOF-161

What it does: Targets the inv(3) chromatin loop that drives EVI1 / MECOM overexpression in the worst-prognosis AML subtype. OWL-P53-INV1 tumor suppressor is restored via destructive-interference frequency targeting at the loop's resonant mode. The loop opens; leukemic transcription stops.

CALORIE: Standard AML therapy (induction chemotherapy) has 30-40% five-year survival; inv(3) AML drops to 5-10%. Frequency-targeted loop disruption opens a path where chemotherapy can't reach.

CURE: Heals the high-risk-cytogenetics deficit. The patients with the worst AML genetics currently have no effective treatment beyond palliative care. Frequency targeting at the chromatin level reaches the geometry of the disease, not its chemistry.

---

Chronic Inflammation — NFκB / TNFα oscillator phase-lock

Substrate atom: narration_health_inflammation_teaching · FOF-162

What it does: NFκB is the master regulator of inflammatory signaling — it oscillates in/out of the nucleus. Chronic inflammation is sustained pathological oscillation. Phase-locking the NFκB cascade at the right frequency calms the signaling through destructive interference.

CALORIE: Current anti-inflammatories (NSAIDs, biologics) block specific molecules. Frequency-targeted phase-lock addresses the oscillator dynamics directly, with fewer off-target effects.

CURE: Heals the chronic-inflammation deficit underlying autoimmune disease, cardiovascular disease, Alzheimer's, and most cancers. Inflammation is upstream of half of modern morbidity; calming the oscillator changes the trajectory of all of it.

---

The paradigm: M_bio → ω_kine

Traditional pharmacology locks onto chemical binding sites. The drug fits the receptor like a key in a lock; mutations in the receptor cause the lock to change shape, and the drug fails — antimicrobial resistance, oncologic resistance.

The M_bio → ω_kine paradigm treats biological systems as oscillators. Disease is sustained pathological oscillation at the wrong frequency. The therapeutic intervention is destructive interference at the resonant kinematic frequency of the disease-driving oscillator — chromatin loops in AML, transcription factors in TB, signaling cascades in inflammation.

The oscillator's frequency is harder to mutate around than its chemical site. The handle is geometric and dynamic, not chemical and static.

The Klein-bottle substrate enforces the C⁴ Constitutional Trust on every protocol — no claim about ω_kine targeting reaches a clinical surface without a substrate-resident SIL V2 scenario, a quorum-signed warrant chain, and a vQbit measurement that the targeting actually held its eight-axis closure.

---

Substrate references